Skip to main content
. 2020 Jul 15;16(7):1091–1098. doi: 10.5664/jcsm.8432

Table 3.

Comparisons between groups with high and low expression of HIF-1α.

HIF-1α High Expression
HIF-1α Low Expression
Odds Ratio P
(n = 14) (n = 8)
Age, y 62.3 ± 10.8 62.3 ± 14.2 1 (.93–1.08) .99
Sex, male 14 7 > .99
Polysomnography
 AHI 46.5 ± 21.8 22.7 ± 22.7 1.05 (1.0–1.11) .04*
 ODI 32.8 ± 21.6 21.4 ± 21.8 1.03 (.98–1.08) .28
 Lowest SpO2 82.3 ± 5.6 82.7 ± 5.4 0.99 (.83–1.17) .88
Tsat90% 14.3 ± 26.2 16.4 ± 27.1 1.0 (.96–1.03) .86
Cancer stage (%)
 Stage I 5 (35) 1 (12) > .99
 Stage II 0 (0) 1 (12)
 Stage III 3 (21) 1 (12) 0.60 (.03–13.5) .75
 Stage IV 6 (43) 5 (63) 0.24 (.02–2.79) .25
Pathology (%)
 Adenocarcinoma 8 (57) 5 (63) > .99
 Squamous cell 4 (29) 2 (25) 1.25 (.16–9.54) .83
 Other 2 (14) 1 (12) 1.25 (.09–17.6) .87

Data presented as mean ± SD or number (percentage). HIF = hypoxia-inducible factor, ODI = oxygen desaturation index, SpO2 = oxygen saturation, Tsat90% = percentage of sleep time with oxygen saturation < 90%.